A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Clinical trial NCT06482190 · UNKNOWN

Trial details

NCT number: NCT06482190
Sponsor: Shenzhen Resproly Biopharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Lung; Disease, Interstitial, With Fibrosis

Start date: 2024-07-11
Primary completion: 2024-12-27
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.